secwatch.observer — SEC 8-K summary
======================================

Issuer:     XOMA Royalty Corp (XOMA)
CIK:        0000791908
Form:       8-K
Filed at:   2025-08-13T23:59:59+00:00
Accession:  0001193125-25-179446
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

XOMA Royalty Q2 net income $9.2M; acquires Turnstone, HilleVax, LAVA; H1 cash receipts $29.6M
--------------------------------------------------------------------------------

- Net income $9.2M (Q2 2025) vs $16.0M (Q2 2024); income & revenue $13.1M vs $11.1M.
- H1 2025 cash receipts $29.6M ($16.0M royalties, $13.6M milestones); Q2 cash receipts $11.7M.
- Completed Turnstone acquisition (Aug 11); HilleVax expected Sept; LAVA expected Q4 2025.
- Deployed $20M for additional mezagitamab royalty; $5M milestone from Rezolute, $3M from Takeda.
- Repurchased 107,500 shares in H1 for $2.4M; paid $2.7M in preferred stock dividends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/791908/000119312525179446/0001193125-25-179446-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/791908/000119312525179446/d852650d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-179446

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer